• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一组喹啉衍生物作为c-MET抑制剂在人类肿瘤治疗中的建模与毒性分析

Modeling and Toxicity Profiling of a Set of Quinoline Derivatives as c-MET Inhibitors in the treatment of Human Tumors.

作者信息

Tuğcu Gülçin, Önen Bayram Filiz Esra, Sipahi Hande

机构信息

Yeditepe University Faculty of Pharmacy, Department of Toxicology, İstanbul, Turkey.

Yeditepe University Faculty of Pharmacy, Department of Pharmaceutical Chemistry, İstanbul, Turkey.

出版信息

Turk J Pharm Sci. 2021 Dec 31;18(6):738-743. doi: 10.4274/tjps.galenos.2021.54815.

DOI:10.4274/tjps.galenos.2021.54815
PMID:34979735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8744432/
Abstract

OBJECTIVES

4-(2-fluorophenoxy) quinoline derivatives constitute one of the chemical classes of hepatocyte growth factor receptor (c-MET) inhibitors, a promising treatment against various human tumors. There are three aims of the present study: (1) To develop a robust and validated quantitative structure-activity relationship model to predict the c-Met kinase inhibition; (2) to examine the toxicity profiles of these compounds; (3) to design new quinoline derivatives and apply the developed model on these compounds to observe its pertinence.

MATERIALS AND METHODS

A multiple linear regression method was used to develop the model with calculated descriptors. State-of-the-art internal and external validation parameters were calculated. The toxicity profiles including structural alerts and the lowest observed adverse effect level (LOAEL) values were evaluated using online tools. New derivatives were designed and tested on the developed model.

RESULTS

A series of 4-(2-fluorophenoxy) quinoline derivatives was linearly modeled and vigorously validated to predict the molecules' c-MET kinase inhibition potential. Statistical metrics of the developed model showed that it was robust and able to make successful predictions for this chemical class. The mass, electronegativity, partial charges, and the structure of the molecules had an effect on the activity. Moreover, the toxicity profiles of the studied compounds were found to be adequate.

CONCLUSION

Five of the synthesized compounds were observed to be auspicious for the toxicity/activity ratio. The developed model is useful in the virtual screening and in the design of new anti-tumor compounds.

摘要

目的

4-(2-氟苯氧基)喹啉衍生物是肝细胞生长因子受体(c-MET)抑制剂的一类化学物质,是一种有前景的针对多种人类肿瘤的治疗药物。本研究有三个目标:(1)建立一个稳健且经过验证的定量构效关系模型,以预测c-Met激酶抑制作用;(2)研究这些化合物的毒性概况;(3)设计新的喹啉衍生物,并将所建立的模型应用于这些化合物,以观察其相关性。

材料与方法

使用多元线性回归方法,利用计算得到的描述符建立模型。计算了最先进的内部和外部验证参数。使用在线工具评估包括结构警示和最低观察到的不良反应水平(LOAEL)值在内的毒性概况。设计了新的衍生物,并在建立的模型上进行测试。

结果

对一系列4-(2-氟苯氧基)喹啉衍生物进行了线性建模并进行了严格验证,以预测分子的c-MET激酶抑制潜力。所建立模型的统计指标表明,它是稳健的,能够对这类化学物质做出成功的预测。分子的质量、电负性、部分电荷和结构对活性有影响。此外,发现所研究化合物的毒性概况是合适的。

结论

观察到五种合成化合物的毒性/活性比很理想。所建立的模型可用于虚拟筛选和新的抗肿瘤化合物的设计。

相似文献

1
Modeling and Toxicity Profiling of a Set of Quinoline Derivatives as c-MET Inhibitors in the treatment of Human Tumors.一组喹啉衍生物作为c-MET抑制剂在人类肿瘤治疗中的建模与毒性分析
Turk J Pharm Sci. 2021 Dec 31;18(6):738-743. doi: 10.4274/tjps.galenos.2021.54815.
2
In silico development, validation and comparison of predictive QSAR models for lipid peroxidation inhibitory activity of cinnamic acid and caffeic acid derivatives using multiple chemometric and cheminformatics tools.运用多种化学计量学和 cheminformatics 工具,对肉桂酸和咖啡酸衍生物的脂质过氧化抑制活性进行了预测 QSAR 模型的计算机辅助开发、验证和比较。
J Mol Model. 2012 Aug;18(8):3951-67. doi: 10.1007/s00894-012-1392-5. Epub 2012 Mar 21.
3
Structure-based discovery of novel 4-(2-fluorophenoxy)quinoline derivatives as c-Met inhibitors using isocyanide-involved multicomponent reactions.基于结构的新型 4-(2-氟苯氧基)喹啉衍生物的发现,作为 c-Met 抑制剂,使用异氰化物参与的多组分反应。
Eur J Med Chem. 2020 May 1;193:112241. doi: 10.1016/j.ejmech.2020.112241. Epub 2020 Mar 16.
4
Design and optimization of novel 4-(2-fluorophenoxy)quinoline derivatives bearing a hydrazone moiety as c-Met kinase inhibitors.新型含腙部分的4-(2-氟苯氧基)喹啉衍生物作为c-Met激酶抑制剂的设计与优化
Eur J Med Chem. 2014 Nov 24;87:508-18. doi: 10.1016/j.ejmech.2014.09.095. Epub 2014 Oct 2.
5
Design, synthesis and biological evaluation of novel 4-(2-fluorophenoxy)quinoline derivatives as selective c-Met inhibitors.新型4-(2-氟苯氧基)喹啉衍生物作为选择性c-Met抑制剂的设计、合成及生物学评价
Bioorg Med Chem. 2017 Feb 1;25(3):886-896. doi: 10.1016/j.bmc.2016.12.002. Epub 2016 Dec 12.
6
Design and biological evaluation of novel 4-(2-fluorophenoxy)quinoline derivatives bearing an imidazolone moiety as c-Met kinase inhibitors.新型含咪唑啉酮部分的4-(2-氟苯氧基)喹啉衍生物作为c-Met激酶抑制剂的设计与生物学评价
Bioorg Med Chem. 2015 Aug 1;23(15):4410-4422. doi: 10.1016/j.bmc.2015.06.026. Epub 2015 Jun 17.
7
Docking and quantitative structure-activity relationship studies for 3-fluoro-4-(pyrrolo[2,1-f][1,2,4]triazin-4-yloxy)aniline, 3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)aniline, and 4-(4-amino-2-fluorophenoxy)-2-pyridinylamine derivatives as c-Met kinase inhibitors.对接和定量构效关系研究 3-氟-4-(吡咯并[2,1-f][1,2,4]三嗪-4-基氧基)苯胺、3-氟-4-(1H-吡咯并[2,3-b]吡啶-4-基氧基)苯胺和 4-(4-氨基-2-氟苯氧基)-2-吡啶基胺衍生物作为 c-Met 激酶抑制剂。
J Comput Aided Mol Des. 2011 Apr;25(4):349-69. doi: 10.1007/s10822-011-9425-1. Epub 2011 Apr 13.
8
Discovery andw biological evaluation of novel 6,7-disubstituted-4-(2-fluorophenoxy)quinoline derivatives possessing 1,2,3-triazole-4-carboxamide moiety as c-Met kinase inhibitors.新型6,7-二取代-4-(2-氟苯氧基)喹啉衍生物作为c-Met激酶抑制剂的发现及其生物学评价,该衍生物含有1,2,3-三唑-4-甲酰胺部分
Bioorg Med Chem. 2014 Nov 15;22(22):6438-52. doi: 10.1016/j.bmc.2014.09.037. Epub 2014 Sep 28.
9
Predictive QSAR modeling of CCR5 antagonist piperidine derivatives using chemometric tools.使用化学计量学工具对CCR5拮抗剂哌啶衍生物进行预测性QSAR建模。
J Enzyme Inhib Med Chem. 2009 Feb;24(1):205-23. doi: 10.1080/14756360802051297.
10
Quantitative Structure-Activity Relationship Study of Camptothecin Derivatives as Anticancer Drugs Using Molecular Descriptors.基于分子描述符的喜树碱衍生物作为抗癌药物的定量构效关系研究
Comb Chem High Throughput Screen. 2019;22(6):387-399. doi: 10.2174/1386207322666190708112251.

引用本文的文献

1
Investigating the Molecular Interactions of Quinoline Derivatives for Antibacterial Activity Against Bacillus subtilis: Computational Biology and In Vitro Study Interpretations.研究喹啉衍生物与枯草芽孢杆菌的抗菌活性的分子相互作用:计算生物学和体外研究解读。
Mol Biotechnol. 2024 Nov;66(11):3252-3273. doi: 10.1007/s12033-023-00933-6. Epub 2023 Nov 6.
2
Cyclohexane-1,3-dione Derivatives as Future Therapeutic Agents for NSCLC: QSAR Modeling, In Silico ADME-Tox Properties, and Structure-Based Drug Designing Approach.环己烷-1,3-二酮衍生物作为非小细胞肺癌的未来治疗药物:定量构效关系建模、计算机辅助药物代谢动力学-毒理学性质研究及基于结构的药物设计方法
ACS Omega. 2023 Jan 19;8(4):4294-4319. doi: 10.1021/acsomega.2c07585. eCollection 2023 Jan 31.

本文引用的文献

1
Design, synthesis and biological evaluation of novel N-[4-(2-fluorophenoxy)pyridin-2-yl]cyclopropanecarboxamide derivatives as potential c-Met kinase inhibitors.新型 N-[4-(2-氟苯氧基)吡啶-2-基]环丙烷甲酰胺衍生物的设计、合成及作为潜在 c-Met 激酶抑制剂的生物评价。
Eur J Med Chem. 2020 May 15;194:112244. doi: 10.1016/j.ejmech.2020.112244. Epub 2020 Mar 20.
2
Structure-based discovery of novel 4-(2-fluorophenoxy)quinoline derivatives as c-Met inhibitors using isocyanide-involved multicomponent reactions.基于结构的新型 4-(2-氟苯氧基)喹啉衍生物的发现,作为 c-Met 抑制剂,使用异氰化物参与的多组分反应。
Eur J Med Chem. 2020 May 1;193:112241. doi: 10.1016/j.ejmech.2020.112241. Epub 2020 Mar 16.
3
MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer.MET 抑制剂在 EGFR TKI 耐药肺癌的靶向治疗中的应用。
J Hematol Oncol. 2019 Jun 21;12(1):63. doi: 10.1186/s13045-019-0759-9.
4
Safety and Tolerability of c-MET Inhibitors in Cancer.癌症中 c-MET 抑制剂的安全性和耐受性。
Drug Saf. 2019 Feb;42(2):211-233. doi: 10.1007/s40264-018-0780-x.
5
Recent advances in the discovery of small molecule c-Met Kinase inhibitors.小分子 c-Met 激酶抑制剂发现的最新进展。
Eur J Med Chem. 2018 Jan 1;143:1103-1138. doi: 10.1016/j.ejmech.2017.08.044. Epub 2017 Aug 24.
6
Targeting in cancer therapy.癌症治疗中的靶向治疗。
Chronic Dis Transl Med. 2017 Jul 19;3(3):148-153. doi: 10.1016/j.cdtm.2017.06.002. eCollection 2017 Sep.
7
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules.SwissADME:一个免费的网络工具,用于评估小分子的药代动力学、类药性和药物化学友善性。
Sci Rep. 2017 Mar 3;7:42717. doi: 10.1038/srep42717.
8
A Historical Excursus on the Statistical Validation Parameters for QSAR Models: A Clarification Concerning Metrics and Terminology.关于 QSAR 模型统计验证参数的历史考察:关于度量和术语的澄清。
J Chem Inf Model. 2016 Jun 27;56(6):1127-31. doi: 10.1021/acs.jcim.6b00088. Epub 2016 Jun 3.
9
ChemDes: an integrated web-based platform for molecular descriptor and fingerprint computation.ChemDes:一个基于网络的用于分子描述符和指纹计算的集成平台。
J Cheminform. 2015 Dec 9;7:60. doi: 10.1186/s13321-015-0109-z. eCollection 2015.
10
pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures.pkCSM:利用基于图的特征预测小分子的药代动力学和毒性特性。
J Med Chem. 2015 May 14;58(9):4066-72. doi: 10.1021/acs.jmedchem.5b00104. Epub 2015 Apr 22.